Decisions for patients with IBD, cancer must be made case-by-case

ORLANDO — Inflammatory bowel disease is a life-altering condition that takes a lifetime of care. Adding it to another life-altering disease, like cancer, makes management decisions much more complicated for physicians, according to experts.At the Advances in Inflammatory Bowel Disease annual meeting, David P. Hudesman, MD, co-director of the Inflammatory Bowel Disease Center at NYU Langone Health, participated in an expert panel discussing several cases weighing the benefit of IBD drugs with cancer risks.A primary concern was how to handle biologics in patients who develop a solidRead More

Share on facebook
Share on twitter
Share on linkedin